Moleculin Biotech, INC. (MBRX) — 10-Q Filings

All 10-Q filings from Moleculin Biotech, INC.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (3)

Moleculin Biotech's Net Loss Widens to $49.1M Amid Warrant Issuances — Nov 13, 2025 Risk: high
Moleculin Biotech, Inc. (MBRX) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $49.112 million, a substantial
Moleculin Biotech Burns Cash, Raises Capital Amidst Zero Revenue — Aug 12, 2025 Risk: high
Moleculin Biotech, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for
Moleculin Biotech Q1 2025: Cash Burn Continues — May 13, 2025 Risk: high
Moleculin Biotech, Inc. filed its Q1 2025 10-Q report on May 13, 2025, for the period ending March 31, 2025. The company reported minimal revenue and significan

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX